Genmab — Maj 2020
-
MGUS progression risk : immune marker alterations & FLC. https://www.onclive.com/insights/early-diagnosis-of-myeloma/mgus-progression-risk-immune-marker-alterations-flc
-
God morgen:-)
-
Tusinde tak bibob.
-
-
Meget godt bud på den følelse man sidder med pt ift gen3013 https://twitter.com/drpaulydesantis/status/1266544262935572481?s=21
-
The
presentations confirmed our suspicion from the ASCO abstracts (Link to Note) that teclistamab
may be emerging as a more effective therapy than bb2121 https://www.twitlonger.com/show/n_1sr8plk -
Teclistamab stjal showet fra epco og ami ved ASCO i Genmab kontext https://twitter.com/ninashah33/status/1267118788136153088?s=21
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind